Press release
Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Landscape 2025: Forecast Data and Growth Strategy Insights
Messenger ribonucleic acid (mRNA) Synthesis Raw Materials
What Is the Expected CAGR for the Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Through 2025?
The market size for raw materials used in messenger ribonucleic acid (mrna) synthesis has seen a slight increase in recent years. The projected growth would be from $2.99 billion in 2024 to $3.03 billion in 2025, a compound annual growth rate (CAGR) of 1.5%. The previous growth can be traced back to advancements in biomedical research, increased attention towards vaccines and therapeutics, the need for personalized medicine, preparedness and response to outbreaks, and the expansion of the biotech industry.
What's the Projected Size of the Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market by 2029?
In the coming years, the market for raw materials used in the synthesis of messenger ribonucleic acid (mrna) is predicted to experience continuous growth. With a compound annual growth rate (CAGR) of 3.5%, the market is expected to reach "$3.48 billion in 2029. Factors contributing to this growth during the forecast period are optimizations in the supply chain, market expansion and commercialization, substantial investment in the biotech and pharma sectors, regulatory support and approvals, as well as therapeutic expansion. The forecast period will also see several major trends such as the advent of new market entrants, a focus on quality control and standardization, matters related to intellectual property and licensing, global access and equity, as well as a shift towards environmentally friendly and scalable production methods.
View the full report here:
https://www.thebusinessresearchcompany.com/report/messenger-ribonucleic-acid-mrna-synthesis-raw-materials-global-market-report
Top Growth Drivers in the Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Industry: What's Accelerating the Market?
The rise in cases of cancer and chronic diseases is anticipated to stimulate the expansion of the mRNA synthesis raw materials market. Cancer is a condition characterized by the uncontrolled growth and spread of abnormal cells, which can infiltrate nearby tissues and potentially migrate to other body parts through the blood and lymph systems. Chronic diseases are broadly defined as conditions that last a year or more, requiring ongoing medical treatment and restricting daily activities. mRNA synthesis raw materials find their application in the fields of drug discovery, vaccine development, and the production of therapeutics based on RNA. They deliver enhanced immunogenicity, greater efficacy, and a reduced production time, proving useful in treating cancer and chronic diseases. For example, the American Cancer Society Facts and Figures revealed that approximately 1.9 million new cancer cases were reported in the US in 2022, resulting in 609,360 deaths. Projections for 2023 suggest a minor rise to over 1.9 million new cases and a death toll of nearly 609,820. Consequently, the escalating cases of cancer and chronic diseases are fuelling the demand for the synthesis of mRNA raw materials.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12336&type=smp
What Are the Key Trends Driving Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Growth?
Innovation in product development is a major trend that is gaining traction in the mRNA synthesis raw materials market. To solidify their position in this competitive market, many key companies are focusing on creating cutting-edge products. For instance, Thermo Fisher Scientific, a US-based company specialized in instrumentation, reagents, consumables, and software services, rolled out a new product line called Dynabeads Solutions in September 2022. These beads are utilized to enhance the GMP-grade synthesis and purification of mRNA, which is crucial for vaccine development. The Dynabeads Streptavidin for In Vitro Transcription are designed to simplify the solid-phase IVT of cell-free mRNA and facilitate the DNA template's reuse up to six times. This not only reduces the necessity for plasmid creation, but also enhances mRNA yield on scales varying from grams to grams. Additionally, the new product aids in creating a streamlined process to help mRNA companies shift swiftly from development to commercialization.
What Are the Main Segments in the Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
The messenger ribonucleic acid (mrna) synthesis raw materials market covered in this report is segmented -
1) By Type: Capping Agents, Nucleotides, Plasmid DNA, Other Types
2) By Applications: Therapeutics Production, Vaccine Production, Other Applications
3) By End-Users: Biotechnology Companies, Pharmaceutical Companies, Research And Academic Institutions, Other End-Users
Subsegments:
1) By Capping Agents: 7-Methyl Guanylate (M7G) Capping Agents, Other Capping Agents
2) By Nucleotides: Natural Nucleotides, Modified Nucleotides, Triphosphate Nucleotides
3) By Plasmid DNA: Linearized Plasmid DNA, Circular Plasmid DNA, High-Purity Plasmid DNA
4) By Other Types: Buffer Solutions, Enzymes, Other Auxiliary Materials
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12336&type=smp
Which Top Companies are Driving Growth in the Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
Major companies operating in the messenger ribonucleic acid (mRNA) synthesis raw materials market include Pfizer Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Moderna Inc., Agilent Technologies Inc., Lonza Group Ltd., Eurofins Scientific, Bio-Rad Laboratories Inc., Qiagen N.V., Maravai LifeSciences, Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Integrated DNA Technologies Inc., Sino Biological Inc., CureVac N.V., LGC Biosearch Technologies, Enzo Biochem Inc, Merck KGaA, GeneCopoeia Inc., Bio-Synthesis Inc., BOC Sciences Inc, Bio Basic Inc., OriGene Technologies Inc., BioCat GmbH, Creative Biogene, Jena Bioscience GmbH, ATDBio Ltd.
Which Regions Will Dominate the Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Through 2029?
North America was the largest region in the mRNA synthesis raw materials market in 2024. The regions covered in the messenger ribonucleic acid (mRNA) synthesis raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12336
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Landscape 2025: Forecast Data and Growth Strategy Insights here
News-ID: 4180616 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
